Literature DB >> 18585098

Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

Takeshi Inagaki1, Vicky Y Lin, Regina Goetz, Moosa Mohammadi, David J Mangelsdorf, Steven A Kliewer.   

Abstract

Starvation blocks the actions of growth hormone (GH) and inhibits growth through mechanisms that are not well understood. In this report, we demonstrate that fibroblast growth factor 21 (FGF21), a hormone induced by fasting, causes GH resistance. In liver, FGF21 reduces concentrations of the active form of signal transducer and activator of transcription 5 (STAT5), a major mediator of GH actions, and causes corresponding decreases in the expression of its target genes, including insulin-like growth factor 1 (IGF-1). FGF21 also induces hepatic expression of IGF-1 binding protein 1 and suppressor of cytokine signaling 2, which blunt GH signaling. Chronic exposure to FGF21 markedly inhibits growth in mice. These data suggest a central role for FGF21 in inhibiting growth as part of its broader role in inducing the adaptive response to starvation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585098      PMCID: PMC2575072          DOI: 10.1016/j.cmet.2008.05.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  37 in total

Review 1.  Binding proteins for the insulin-like growth factors: structure, regulation and function.

Authors:  R C Baxter; J L Martin
Journal:  Prog Growth Factor Res       Date:  1989

2.  Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.

Authors:  S Guo; G Rena; S Cichy; X He; P Cohen; T Unterman
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

3.  Plasma somatomedin-C in fasted and refed rats: close relationship with changes in liver somatogenic but not lactogenic binding sites.

Authors:  M Maes; L E Underwood; J M Ketelslegers
Journal:  J Endocrinol       Date:  1983-05       Impact factor: 4.286

Review 4.  The role of STAT proteins in growth hormone signaling.

Authors:  J Herrington; L S Smit; J Schwartz; C Carter-Su
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Transcriptional regulation of rat insulin-like growth factor-binding protein-1 expression by growth hormone.

Authors:  C Seneviratne; J M Luo; L J Murphy
Journal:  Mol Endocrinol       Date:  1990-08

Review 6.  Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.

Authors:  Derek LeRoith; Shoshana Yakar
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-03

Review 7.  Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

Authors:  Elizabeth Rico-Bautista; Amilcar Flores-Morales; Leandro Fernández-Pérez
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-27       Impact factor: 7.638

8.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

9.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.

Authors:  Takeshi Inagaki; Paul Dutchak; Guixiang Zhao; Xunshan Ding; Laurent Gautron; Vinay Parameswara; Yong Li; Regina Goetz; Moosa Mohammadi; Victoria Esser; Joel K Elmquist; Robert D Gerard; Shawn C Burgess; Robert E Hammer; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

10.  betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.

Authors:  Masashi Suzuki; Yuriko Uehara; Kaori Motomura-Matsuzaka; Junko Oki; Yoshinori Koyama; Miho Kimura; Masahiro Asada; Akiko Komi-Kuramochi; Syuichi Oka; Toru Imamura
Journal:  Mol Endocrinol       Date:  2008-01-10
View more
  174 in total

Review 1.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 2.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

Review 3.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

4.  Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.

Authors:  Wei Wei; Paul A Dutchak; Xunde Wang; Xunshan Ding; Xueqian Wang; Angie L Bookout; Regina Goetz; Moosa Mohammadi; Robert D Gerard; Paul C Dechow; David J Mangelsdorf; Steven A Kliewer; Yihong Wan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

5.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

6.  FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.

Authors:  Dong-Ju Shin; Timothy F Osborne
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

7.  Acromegaly is associated with high fibroblast growth factor-21 levels.

Authors:  B S Yurekli; N O Kutbay; M Aksit; A Suner; I Y Simsir; S Seckiner; G U Kocabas; G Bozkaya; F Saygili
Journal:  J Endocrinol Invest       Date:  2018-05-12       Impact factor: 4.256

8.  Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop.

Authors:  Rucha Patel; Angie L Bookout; Lilia Magomedova; Bryn M Owen; Giulia P Consiglio; Makoto Shimizu; Yuan Zhang; David J Mangelsdorf; Steven A Kliewer; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-12-11

Review 9.  Curcumin and dietary polyphenol research: beyond drug discovery.

Authors:  Tian-Ru Jin
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150

Review 10.  Fibroblast growth factor 21: from pharmacology to physiology.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.